Imatinib mesylate as treatment for blastic transformation of Philadelphia chromosome positive chronic myelogenous leukemia.
Year: 2003
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: Anna Sureda, Marina Carrasco, Miguel de Miguel, Jesùs A Martínez, Eulogio Conde, Miguel A Sanz, Joaquin Díaz-Mediavilla, Jorge Sierra
Institution: Hospital de Sant Pau
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: imatinib mesylate, imatinib, Philadelphia chromosome-positive chronic myelogenous leukemia, blast crisis, BCR-ABL tyrosine kinase inhibitors, hematologic remission, cytogenetic remission, event-free survival, overall survival, prognostic factors, time to treatment, complex karyotype, extramedullary involvement
Open Access status: closed
OpenAlex ID: W2096135025
